XML 53 R13.htm IDEA: XBRL DOCUMENT
v3.20.1

ACCRUED LIABILITIES | 12 Months Ended
--- | ---
Dec. 31, 2019
Payables And Accruals [Abstract] |
ACCRUED LIABILITIES | 5. ACCRUED LIABILITIES Accrued liabilities consisted of the following:
|  | December 31, |
(In thousands) |  | 2019 |  |  | 2018 |
CRO and clinical trial costs |  | $ | 5,263 |  |  | $ | 529 |
Manufacturing activities |  |  | 1,740 |  |  |  | — |
Professional legal and accounting fees |  |  | 318 |  |  |  | 327 |
Other |  |  | 207 |  |  |  | 461 |
|  | $ | 7,528 |  |  | $ | 1,317 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration